


Ask a doctor about a prescription for DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Desloratadine Viatris 5 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Desloratadine Viatris is a non-drowsy antihistamine medicine that helps to control allergic reactions and their symptoms.
Desloratadine is indicated in adults and adolescents (12 years of age and older) to relieve the symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, such as hay fever or house dust mite allergy). These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red, or watery eyes.
Desloratadine is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.
Relief of these symptoms lasts a full day and helps you to carry out your daily activities and sleep.
You should consult a doctor if your symptoms worsen or do not improve.
Do not take Desloratadine Viatris
Warnings and precautions
Consult your doctor or pharmacist before taking Desloratadine Viatris if:
If you are not sure if any of these apply to you, ask your doctor or pharmacist.
Children
Desloratadine tablets are not suitable for children under 12 years of age.
Other medicines and Desloratadine Viatris
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking Desloratadine Viatris with alcohol
Be careful when taking desloratadine with alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Desloratadine Viatris is not recommended if you are pregnant or breastfeeding.
Driving and using machines
At the recommended dose, desloratadine is not expected to cause drowsiness or affect your ability to drive or use machines. However, in rare cases, some people may experience drowsiness, which may affect their ability to drive or use machines.
Desloratadine Viatris contains sunset yellow FCF (E110) and sodium
Sunset yellow FCF (E 110) may cause allergic reactions.
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet, which is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose for adults and adolescents (12 years of age and older) is one tablet once a day.
Swallow the tablet whole with a glass of water, with or without food.
Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you have and how long you should take desloratadine.
If your allergic rhinitis is intermittent (symptoms present for less than 4 days a week or for less than 4 weeks), your doctor will recommend a treatment plan based on the evaluation of your medical history.
If your allergic rhinitis is persistent (symptoms present for 4 or more days a week and for more than 4 weeks), your doctor may recommend long-term treatment.
For urticaria, the duration of treatment may vary from one patient to another, and you should follow your doctor's instructions.
If you take more Desloratadine Viatris than you should
Take desloratadine only as your doctor has told you. An accidental overdose is not expected to cause serious problems.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Desloratadine Viatris
If you forget to take your dose at the scheduled time, take it as soon as possible and then continue with your regular dosing schedule. Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. In adults, side effects were approximately the same as with a placebo tablet. However, fatigue, dry mouth, and headache were reported more frequently with desloratadine than with the placebo tablet. In adolescents, headache was the most frequently reported side effect.
If you experience any of the following side effects, stop taking this medicine and contact your doctor or go to the emergency department of your nearest hospital immediately:
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
In clinical trials with desloratadine, the following side effects were reported as:
Frequent (may affect up to 1 in 10 people):
During the marketing of desloratadine, the following side effects were reported in adults as:
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
Other side effects in children and adolescents
Frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton, blister, and bottle after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Desloratadine Viatris
The active substance is desloratadine. Each tablet contains 5 mg of desloratadine.
The other ingredients are: magnesium stearate (E 572), sodium lauryl sulfate (E 487), anhydrous colloidal silica (E 551), microcrystalline cellulose (E 460i), and pregelatinized corn starch.
The tablet coating contains: polyvinyl alcohol (E 1203), carmine indigo aluminum lake (E 132), sunset yellow FCF aluminum lake (E 110), macrogol, talc (E 553b), and titanium dioxide (E 171).
See section 2, "Desloratadine Viatris contains sunset yellow FCF (E110) and sodium".
Appearance of the product and pack contents
Desloratadine Viatris are blue, round, curved-sided tablets marked with "DE 5" on one side and an "M" on the other.
Desloratadine Viatris 5 mg film-coated tablets are packaged in blisters containing 10, 15, 20, 30, 50, 60, 90, 100 tablets or in bottles containing 30 and 250 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer:
McDermott Laboratories Limited t/a Gerard Laboratories
35/36 Baldoyle Industrial Estate
Grange Road, Dublin 13
Ireland
or
VIATRIS SANTE
360 Avenue Henri Schneider
69300 Meyzieu
France
or
Mylan Hungary Kft. / Mylan Hungary Ltd.
Mylan utca 1
Komárom, 2900
Hungary
You can request more information about this medicine from the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
SpainDesloratadine Viatris 5 mg film-coated tablets EFG
FranceDesloratadine Viatris 5 mg, film-coated tablet
ItalyDesloratadine Mylan Generics
NetherlandsDesloratadine Viatris 5 mg, film-coated tablets
United Kingdom (Northern Ireland)Desloratadine Mylan 5mg Film-coated Tablets
Czech RepublicDesloratadine Viatris 5mg, film-coated tablets
SwedenDesloratadine Viatris 5 mg film-coated tablet
Date of last revision of this leaflet:July 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) https://www.aemps.gob.es/
The average price of DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS in November, 2025 is around 6.63 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DESLORATADINE VIATRIS 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.